Official stocks to watch in 2013.......... ongoing
- Thread starter water
- Start date
Will keep an eye on this stock, but it looks like it won't be a hit yet. It's at $0.03 now.
just opened up my TD Ameritrade account! Shit is time consuming that makes me have 3 accounts to watch over daily. Waiting on my big account stock to hit 92ish so I can sell and make a few bucks on my stocks. Then wait for it to drop a few bucks and buy back in. Slowly but surely
This stock just trades between $0.03-$0.04 every damn day.
The 52 week high is $.05. Dude must have a million shares if he made any money off it.
get in to mjna accccceeeeee ffuuccckking sappppppppp
look into cal dive brothers. They are in the oil industry and are making moves. I go in at about a buck and have seen steady returns.
just to be clear, I go this info from an offshore guy I know. I am not a stock guru, nor do I pretend to be. According to this guy, they have secured a long term contract overseas.
Kaya, I'm going to hit you up later brother.
just to be clear, I go this info from an offshore guy I know. I am not a stock guru, nor do I pretend to be. According to this guy, they have secured a long term contract overseas.
Kaya, I'm going to hit you up later brother.
SIRIUS XM Radio Inc. (SIRI)
-NasdaqGS
3.23 Up 0.09(2.87%) 4:00PM EST|After Hours : 3.24 Up 0.01 (0.31%) 4:44PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close: 3.14
Open: 3.17
Bid: 3.23 x 81800
Ask: 3.24 x 28700
1y Target Est: 3.35
Beta: 1.66
Next Earnings Date: 5-Feb-13SIRI Earnings announcement
Day's Range: 3.16 - 3.25
52wk Range: 1.78 - 3.19
Volume: 82,208,339
Avg Vol (3m): 66,466,600
Market Cap: 16.82B
P/E (ttm): 6.35
EPS (ttm): 0.51
Div & Yield: N/A (N/A
-NasdaqGS
3.23 Up 0.09(2.87%) 4:00PM EST|After Hours : 3.24 Up 0.01 (0.31%) 4:44PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close: 3.14
Open: 3.17
Bid: 3.23 x 81800
Ask: 3.24 x 28700
1y Target Est: 3.35
Beta: 1.66
Next Earnings Date: 5-Feb-13SIRI Earnings announcement
Day's Range: 3.16 - 3.25
52wk Range: 1.78 - 3.19
Volume: 82,208,339
Avg Vol (3m): 66,466,600
Market Cap: 16.82B
P/E (ttm): 6.35
EPS (ttm): 0.51
Div & Yield: N/A (N/A
Colin alert --- read mudafuckas read
Since we recommended buying Medical Marijuana (MJNA.PK) it's up 89%. Other pot stocks are also doing well, such as Cannabis Science (CBIS.OB) up more than 2% today. There wasn't any news release today that would cause the stock to rise so sharply. We suspect that the company has been discovered as a profitable investment for reasons we've outlined before, as well as a growing interest in the budding Marijuana industry.
We couldn't write a specific article on MJNA because it was still a micro-cap, but now it's market cap is 148M. Currently it's trading at .202 which is its current all time high. The stock has proven itself as a true small cap representative of a new growth industry.
Many traders know the mantra "Don't buy the high" which has solid foundation. But we believe Medical Marijuana is going higher, and here's why.
Earnings
Unlike other companies in the pot business, Medical Marijuana has solid revenue and prospects for revenue growth. Their gross revenues increased 1,100% from the previous year quarter.
Medical Marijuana Inc (PINK: MJNA) augmented 1.09% to $0.177 on a traded volume of 1.61 million shares. The Company pre-announces its fourth quarter earnings. The net income was $3.39 million in the fourth quarter. The gross revenues were $5.10 million, an increase of $4.5 million and over 1,100% from the previous year quarter. The Company provided an update on the expansion of its Red Dice Holdings Dixie Elixirs & Edibles brand nationally and in Colorado through additional market penetration and product development.
Their return on average assets is 59% which is huge, compared to most publicly traded companies. For example Microsoft (MSFT) has a return on average assets of 14% for 2012. Google's (GOOG) return on average assets is 12%.
Google Finance reports institutional ownership of 0%, a very encouraging sign for growth, as an institutional purchase could drive the price higher.
Financials like this are hard to find.
Patents
The company owns a portfolio of patents encompassing multiple vertical markets, but with a focus on medical marijuana (vs. casual use).
MJNA provides over 50 proprietary and patented cannabinoid "delivery methods" that are more "socially and medically acceptable" than smoking. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.
Industry gaining support
In Pennsylvania, a state senator has proposed a Marijuana legalization bill.
State Sen. Daylin Leach, a Democrat representing Montgomery and Delaware counties, announced plans Tuesday to introduce legislation that would legalize marijuana in Pennsylvania.
He has two co-sponsors on the bill -- Democrats from Philadelphia and Pittsburgh -- and plans to introduce the bill within the next week for the 2013-14 legislative session.
Leach during the Legislature's 2011-12 session introduced Senate Bill 1089 to create a medical marijuana program, but the measure did not make it out of committee.
60 Minutes did a segment on the industry, showing to average TV viewers some of the professional business aspects of the industry. Shows like this are starting to spread knowledge of the trend to the mainstream. While the movement to legalize has a cult following, it still is not part of the mainstream culture.
The risks
Of course, being a fairly new company there are a number of things that could go wrong as is the case with anything new. Also, Marijuana is still illegal on a Federal level. While the Obama administration has promoted a hands-off policy regarding states legalization, that could change.
Long MJNA
If you'd like some exposure to this budding industry, we believe Medical Marijuana is the best play. It has the most potential for growth and is positioned to capitalize on further legalization measures.
It's hard to say how high MJNA might go, we've heard analysts target $1 in a year. To get in at a good price, the strategy here would be to buy on dips (not at it's current highs). Today's high proves that it's not like competitor companies whose stocks have lingered.
Since we recommended buying Medical Marijuana (MJNA.PK) it's up 89%. Other pot stocks are also doing well, such as Cannabis Science (CBIS.OB) up more than 2% today. There wasn't any news release today that would cause the stock to rise so sharply. We suspect that the company has been discovered as a profitable investment for reasons we've outlined before, as well as a growing interest in the budding Marijuana industry.
We couldn't write a specific article on MJNA because it was still a micro-cap, but now it's market cap is 148M. Currently it's trading at .202 which is its current all time high. The stock has proven itself as a true small cap representative of a new growth industry.
Many traders know the mantra "Don't buy the high" which has solid foundation. But we believe Medical Marijuana is going higher, and here's why.
Earnings
Unlike other companies in the pot business, Medical Marijuana has solid revenue and prospects for revenue growth. Their gross revenues increased 1,100% from the previous year quarter.
Medical Marijuana Inc (PINK: MJNA) augmented 1.09% to $0.177 on a traded volume of 1.61 million shares. The Company pre-announces its fourth quarter earnings. The net income was $3.39 million in the fourth quarter. The gross revenues were $5.10 million, an increase of $4.5 million and over 1,100% from the previous year quarter. The Company provided an update on the expansion of its Red Dice Holdings Dixie Elixirs & Edibles brand nationally and in Colorado through additional market penetration and product development.
Their return on average assets is 59% which is huge, compared to most publicly traded companies. For example Microsoft (MSFT) has a return on average assets of 14% for 2012. Google's (GOOG) return on average assets is 12%.
Google Finance reports institutional ownership of 0%, a very encouraging sign for growth, as an institutional purchase could drive the price higher.
Financials like this are hard to find.
Patents
The company owns a portfolio of patents encompassing multiple vertical markets, but with a focus on medical marijuana (vs. casual use).
MJNA provides over 50 proprietary and patented cannabinoid "delivery methods" that are more "socially and medically acceptable" than smoking. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.
Industry gaining support
In Pennsylvania, a state senator has proposed a Marijuana legalization bill.
State Sen. Daylin Leach, a Democrat representing Montgomery and Delaware counties, announced plans Tuesday to introduce legislation that would legalize marijuana in Pennsylvania.
He has two co-sponsors on the bill -- Democrats from Philadelphia and Pittsburgh -- and plans to introduce the bill within the next week for the 2013-14 legislative session.
Leach during the Legislature's 2011-12 session introduced Senate Bill 1089 to create a medical marijuana program, but the measure did not make it out of committee.
60 Minutes did a segment on the industry, showing to average TV viewers some of the professional business aspects of the industry. Shows like this are starting to spread knowledge of the trend to the mainstream. While the movement to legalize has a cult following, it still is not part of the mainstream culture.
The risks
Of course, being a fairly new company there are a number of things that could go wrong as is the case with anything new. Also, Marijuana is still illegal on a Federal level. While the Obama administration has promoted a hands-off policy regarding states legalization, that could change.
Long MJNA
If you'd like some exposure to this budding industry, we believe Medical Marijuana is the best play. It has the most potential for growth and is positioned to capitalize on further legalization measures.
It's hard to say how high MJNA might go, we've heard analysts target $1 in a year. To get in at a good price, the strategy here would be to buy on dips (not at it's current highs). Today's high proves that it's not like competitor companies whose stocks have lingered.
Industrial Hemp and Medical Marijuana Industry Hits All-Time High in 2013
LAS VEGAS, Feb. 4, 2013 /PRNewswire/ – Recent activity in the markets has pushed the industrial hemp and medical marijuana sectors to new heights, setting a record volume of Hemp, Inc.'s (HEMP) traded shares of 70,226,200 this past week. Hemp, Inc. (HEMP), the industry leader that led the last growth curve back in 2009 with a 480% increase, is, again, leading the industry in 2013 as its CEO, Bruce Perlowin, predicted. According to Perlowin, the pioneer of the industry, the last spike was only a precursor to what is happening now in an industry that is officially "unstoppable."
(Logo: http://photos.prnewswire.com/prnh/20121107/LA08133LOGO)
As one of the largest publicly-traded companies of hemp stocks in the United States, by market capitalization, Hemp, Inc. (HEMP) has poised itself as the leader in the industry. The company Hemp, Inc. (HEMP) has been dousing the industrial hemp market with hemp-based products, expanding its divisions and working to complete the spin-off of non-core related subsidiaries. Strategist and CEO of Hemp, Inc. (HEMP) Bruce Perlowin has also laid out the most powerful and profitable purchasing mechanism in the history of marketing which he calls the "Quantum Economic Purchasing Matrix." This is the next phase of moving from a developmental stage company to an operating company which means a full scale launch under their sales and marketing program. Full implementation of this humanity-serving model is set for the second quarter. (Listen to recorded conference call here.)
This humanity-serving model, is no easy feat even for a man who knows every nuance of the industry and who pioneered solutions for the industry such as a tax remittance card. With this card, Hemp, Inc. is able to track all taxes collected, on a daily basis, and remit the proper amount of tax to the proper authorities based upon their requirements. This can be a windfall for state and local governments. Along with the tax remittance card, Hemp, Inc. offers other comprehensive solutions to the industry that covers inventory control which tracks products from seed to sale; educational expos; and seminars to educate entrepreneurs on the shifting laws and realities of the medical marijuana and industrial hemp industry.
While educating consumers on the many uses of industrial hemp, Hemp, Inc. (HEMP) (www.hemp.com), is also producing hemp-based products proven to increase the body's overall health and performance. The company boasts HerbaGenix™ nutraceuticals (www.herbagenix.com); BasicHemp (www.basichemp.com), their hemp protein shakes brand; and, custom-branded MJ Lover for Him and MJ Lover for Her (www.mjlover.com) and Re-Load's hemp nutraceuticals (www.re-load.biz) which are derived from a blend of organic nutrients, herbs, and vitamins including hemp extract, and AFA blue-green algae which is known for its healthful effects.
Other products include hemp gemstone candles (www.supportpatchadams.com) made on the Kins Domain; the Eco-Harmony Loyalty Card (www.ecoharmonycards.com); Hemp, Inc.'s flagship website and aged URL (www.hemp.com) which is the portal for all industrial hemp products and what is quickly becoming the "Amazon" of the industrial hemp industry; hemp and natural fibre clothing (www.cartelblue.com) coming Spring 2013; education and media (www.marijuanaincorporated.com); and Hemp, Inc.'s Hemp Ambassador program, which Perlowin discussed during TheStockRadio.com's radio interview.
The original founder of Medical Marijuana, Inc., and one of the first leaders promulgating a viable medical marijuana public company which has paved the way for other marijuana stock companies to follow, Bruce Perlowin is indeed a proven innovative, savvy, aggressive entrepreneur and progressive advocate of the medical marijuana and hemp industries. According to Perlowin's son, Aubree Arias, CEO of Compassion Capitol, LLC, his father has, "made great strides in unifying and educating the public about the hemp industry. Before my father took Medical Marijuana, Inc. public, there were no publicly traded corporations in this arena. He had the courage to be a pioneer and risk bringing Medical Marijuana, Inc. into the public equities market. Taking on the stigma associated with hemp has not been an easy road, but he has paved the way, and we are seeing the fruits of that with over a dozen publicly traded entities in this sector. Now we are poised to have Hemp, Inc. (www.hemp.com) become the 'Amazon' of the hemp world, as we expect rapid growth in the industry."
Last year, in early November, Perlowin was quoted saying, "I foresee another spike after the elections, because there are too many states voting for legalization. Even if a few states pass, it will clearly show the market that this industry has just made a quantum leap forward… approaching that tipping point where this industry experiences an explosive, exponential growth curve. The millions of shares traded in each company of the Fabulous Four clearly indicate that the investment community sees this industry is here to stay and that they want in at the beginning of the next growth curve that any victory in any of the states the elections will bring us," says Perlowin. Last week, the Fabulous Four collectively sold over a quarter of a billion shares.
Over the past week, the top four hemp and marijuana stock companies Hemp, Inc. (HEMP), GrowLife, Inc. (PHOT), GreenGro (GRNH), and Medical Marijuana, Inc. (MJNA) otherwise known as the "Fabulous Four" have seen significant growth. The Fabulous Four currently represents what stock market analysts call a classic bull market, whereby stock prices as a whole move upward for a prolonged period of time. The rate at which those gains occur can vary widely from bull market to bull market. The duration of a bull market, the severity of the falling market that follows, and the time that elapses until the next upturn are also different each time. However, according to Perlowin, this is the beginning of a long-term solid upward trend, as the odds are "in our favor." The initial stages of the current spike, shows Hemp, Inc. grew 55.2% in the last few days alone.
Sterling Scott, Grow Life's CEO said, "Our industry sector is experiencing a very strong tail wind from much more favorable public perceptions and the fast pace of regulation reform". Scott went on to explain that, "Expansion and growth are very strong trends today. We think this is because the scale of the opportunity for GrowLife (PHOT) and other Medical Marijuana centric public companies is increasing geometrically. Fund investors and retail investors alike, are becoming very interested in our stock and they do not want to be left behind and miss out on solid long term investment opportunities."
Michelle Sides, Esq. of Medical Marijuana, Inc. said, "As the oldest medical marijuana publicly traded company in America, the last 30 days clearly indicate that our industry is moving into hyperdrive, attracting investors at an unprecedented rate, up to this point. The entire Fabulous Four hemp and medical marijuana stocks are experiencing the same thing, reminiscent of a dot.com explosion. They are all banking on the future and the future is just now coming to the forefront in mainstream America everywhere. Our stock skyrocketed from 10 cents to over 30 cents."
James Holt, CEO and Grower of GreenGro Technologies said, "As our industry continues to mature and evolve we are seeing a shift from a wild-west mentality to companies in this industry focusing on solid business fundamentals and long term growth. The top echelon of this nascent industry are delivering extraordinary returns for investors and generating real revenues and profits now, and are positioned well for future growth."
Perlowin also owns stock in the other 3 companies GrowLife, Inc. (PHOT), GreenGro Technologies (GRNH), Medical Marijuana, Inc. (MJNA) and is negotiating to showcase and demonstrate the effectiveness of the advanced growing technologies on his Kin's Domain project in Dolan Springs, Arizona (www.kinsdomain.us). This back-to-the-land sustainable movement is where some of Hemp, Inc.'s hemp products are manufactured. Perlowin states, "Hemp, Inc., GrowLife, Inc., GreenGro Technologies, and Medical Marijuana Inc. are the four fastest growing industrial hemp and medical marijuana stocks in the industry so it's only natural that we all work together in a synergistic economic relationship. Perlown further stated, "Whenever anyone asks me where I should invest in this industry, I always point to Fabulous Four. Spreading your investment portfolio is always a wise decision and its human nature to do that anyways. I'm in support of the entire industry, not just my own company Hemp, Inc. (HEMP)."
LAS VEGAS, Feb. 4, 2013 /PRNewswire/ – Recent activity in the markets has pushed the industrial hemp and medical marijuana sectors to new heights, setting a record volume of Hemp, Inc.'s (HEMP) traded shares of 70,226,200 this past week. Hemp, Inc. (HEMP), the industry leader that led the last growth curve back in 2009 with a 480% increase, is, again, leading the industry in 2013 as its CEO, Bruce Perlowin, predicted. According to Perlowin, the pioneer of the industry, the last spike was only a precursor to what is happening now in an industry that is officially "unstoppable."
(Logo: http://photos.prnewswire.com/prnh/20121107/LA08133LOGO)
As one of the largest publicly-traded companies of hemp stocks in the United States, by market capitalization, Hemp, Inc. (HEMP) has poised itself as the leader in the industry. The company Hemp, Inc. (HEMP) has been dousing the industrial hemp market with hemp-based products, expanding its divisions and working to complete the spin-off of non-core related subsidiaries. Strategist and CEO of Hemp, Inc. (HEMP) Bruce Perlowin has also laid out the most powerful and profitable purchasing mechanism in the history of marketing which he calls the "Quantum Economic Purchasing Matrix." This is the next phase of moving from a developmental stage company to an operating company which means a full scale launch under their sales and marketing program. Full implementation of this humanity-serving model is set for the second quarter. (Listen to recorded conference call here.)
This humanity-serving model, is no easy feat even for a man who knows every nuance of the industry and who pioneered solutions for the industry such as a tax remittance card. With this card, Hemp, Inc. is able to track all taxes collected, on a daily basis, and remit the proper amount of tax to the proper authorities based upon their requirements. This can be a windfall for state and local governments. Along with the tax remittance card, Hemp, Inc. offers other comprehensive solutions to the industry that covers inventory control which tracks products from seed to sale; educational expos; and seminars to educate entrepreneurs on the shifting laws and realities of the medical marijuana and industrial hemp industry.
While educating consumers on the many uses of industrial hemp, Hemp, Inc. (HEMP) (www.hemp.com), is also producing hemp-based products proven to increase the body's overall health and performance. The company boasts HerbaGenix™ nutraceuticals (www.herbagenix.com); BasicHemp (www.basichemp.com), their hemp protein shakes brand; and, custom-branded MJ Lover for Him and MJ Lover for Her (www.mjlover.com) and Re-Load's hemp nutraceuticals (www.re-load.biz) which are derived from a blend of organic nutrients, herbs, and vitamins including hemp extract, and AFA blue-green algae which is known for its healthful effects.
Other products include hemp gemstone candles (www.supportpatchadams.com) made on the Kins Domain; the Eco-Harmony Loyalty Card (www.ecoharmonycards.com); Hemp, Inc.'s flagship website and aged URL (www.hemp.com) which is the portal for all industrial hemp products and what is quickly becoming the "Amazon" of the industrial hemp industry; hemp and natural fibre clothing (www.cartelblue.com) coming Spring 2013; education and media (www.marijuanaincorporated.com); and Hemp, Inc.'s Hemp Ambassador program, which Perlowin discussed during TheStockRadio.com's radio interview.
The original founder of Medical Marijuana, Inc., and one of the first leaders promulgating a viable medical marijuana public company which has paved the way for other marijuana stock companies to follow, Bruce Perlowin is indeed a proven innovative, savvy, aggressive entrepreneur and progressive advocate of the medical marijuana and hemp industries. According to Perlowin's son, Aubree Arias, CEO of Compassion Capitol, LLC, his father has, "made great strides in unifying and educating the public about the hemp industry. Before my father took Medical Marijuana, Inc. public, there were no publicly traded corporations in this arena. He had the courage to be a pioneer and risk bringing Medical Marijuana, Inc. into the public equities market. Taking on the stigma associated with hemp has not been an easy road, but he has paved the way, and we are seeing the fruits of that with over a dozen publicly traded entities in this sector. Now we are poised to have Hemp, Inc. (www.hemp.com) become the 'Amazon' of the hemp world, as we expect rapid growth in the industry."
Last year, in early November, Perlowin was quoted saying, "I foresee another spike after the elections, because there are too many states voting for legalization. Even if a few states pass, it will clearly show the market that this industry has just made a quantum leap forward… approaching that tipping point where this industry experiences an explosive, exponential growth curve. The millions of shares traded in each company of the Fabulous Four clearly indicate that the investment community sees this industry is here to stay and that they want in at the beginning of the next growth curve that any victory in any of the states the elections will bring us," says Perlowin. Last week, the Fabulous Four collectively sold over a quarter of a billion shares.
Over the past week, the top four hemp and marijuana stock companies Hemp, Inc. (HEMP), GrowLife, Inc. (PHOT), GreenGro (GRNH), and Medical Marijuana, Inc. (MJNA) otherwise known as the "Fabulous Four" have seen significant growth. The Fabulous Four currently represents what stock market analysts call a classic bull market, whereby stock prices as a whole move upward for a prolonged period of time. The rate at which those gains occur can vary widely from bull market to bull market. The duration of a bull market, the severity of the falling market that follows, and the time that elapses until the next upturn are also different each time. However, according to Perlowin, this is the beginning of a long-term solid upward trend, as the odds are "in our favor." The initial stages of the current spike, shows Hemp, Inc. grew 55.2% in the last few days alone.
Sterling Scott, Grow Life's CEO said, "Our industry sector is experiencing a very strong tail wind from much more favorable public perceptions and the fast pace of regulation reform". Scott went on to explain that, "Expansion and growth are very strong trends today. We think this is because the scale of the opportunity for GrowLife (PHOT) and other Medical Marijuana centric public companies is increasing geometrically. Fund investors and retail investors alike, are becoming very interested in our stock and they do not want to be left behind and miss out on solid long term investment opportunities."
Michelle Sides, Esq. of Medical Marijuana, Inc. said, "As the oldest medical marijuana publicly traded company in America, the last 30 days clearly indicate that our industry is moving into hyperdrive, attracting investors at an unprecedented rate, up to this point. The entire Fabulous Four hemp and medical marijuana stocks are experiencing the same thing, reminiscent of a dot.com explosion. They are all banking on the future and the future is just now coming to the forefront in mainstream America everywhere. Our stock skyrocketed from 10 cents to over 30 cents."
James Holt, CEO and Grower of GreenGro Technologies said, "As our industry continues to mature and evolve we are seeing a shift from a wild-west mentality to companies in this industry focusing on solid business fundamentals and long term growth. The top echelon of this nascent industry are delivering extraordinary returns for investors and generating real revenues and profits now, and are positioned well for future growth."
Perlowin also owns stock in the other 3 companies GrowLife, Inc. (PHOT), GreenGro Technologies (GRNH), Medical Marijuana, Inc. (MJNA) and is negotiating to showcase and demonstrate the effectiveness of the advanced growing technologies on his Kin's Domain project in Dolan Springs, Arizona (www.kinsdomain.us). This back-to-the-land sustainable movement is where some of Hemp, Inc.'s hemp products are manufactured. Perlowin states, "Hemp, Inc., GrowLife, Inc., GreenGro Technologies, and Medical Marijuana Inc. are the four fastest growing industrial hemp and medical marijuana stocks in the industry so it's only natural that we all work together in a synergistic economic relationship. Perlown further stated, "Whenever anyone asks me where I should invest in this industry, I always point to Fabulous Four. Spreading your investment portfolio is always a wise decision and its human nature to do that anyways. I'm in support of the entire industry, not just my own company Hemp, Inc. (HEMP)."
Mjna ASAP ASAP ASAP
Medical Marijuana, Inc: The Secret To Legally Tapping Into The Market For THC------—;()/:
//-//////
The acceptance of marijuana as a medicine is slowly gaining popularity. This market alone has a tremendous potential to change the landscape of the pharmaceutical product lines as more and more states allow their citizens access to marijuana. But medicinal marijuana is only half of the market. The other half of the market is selling marijuana for recreational use. Let's face it: some people just want to get high. Until now, most thought that Medbox, Inc. (MDBX.PK) was the only legitimate route to investing in the marijuana industry that included THC, which is the component in marijuana that provides the psychotropic effects (the buzz) that recreational users desire. But Medical Marijuana, Inc. (MJNA.PK) also has a method for legal entry into the market for the effects of THC that is not widely understood. I'm talking about licensing.
Medbox's primary value is derived from its subsidiary Prescription Vending Machines, Inc. Medbox provides a way for entrepreneurs in the medical marijuana industry to sell their products without a sales force. Transactions are completed using vending machines that read biometric input from users to verify identity for authorization to receive the dispensed products.
(click to enlarge)
This ability to legally reach the market and show actual results has proven to be extremely rewarding for some shareholders of Medbox. The six month chart above from Yahoo Finance shows a whopping increase of 2,595%.
Initially trading around $2.90, the stock briefly soared as high as $205 in mid-November before steadying to trade around its January 18th closing price of $78.15. Medbox recently announced a 1000% increase in cash reserves in its January 2, 2013 Q4 revenue figures from the prior quarter. Some believe that Medbox could decline as much as 50%. There is no doubt that Medbox seems to be extremely overpriced. Luckily, there are other alternatives to investing in the marijuana industry's THC-focused market that are more reasonably priced.
The portion of the market mentioned above that looks to use marijuana for recreational use is not completely untapped. Obviously, some who claim to need medicinal benefits do so just to gain access for leisure. But even if you exclude those who have found loopholes to gaining access, there is still a large population that will use marijuana as more and more states legalize recreational use. With Colorado and Washington leading the U.S. with their legalization of recreational use, you can be sure that other states will follow. Hawaii state House Speaker Joe Souki introduced House Bill 150, the Personal Use of Marijuana Act, which would allow adults that are 21 years or older to have a limited amount of marijuana for personal use.
With an established medical marijuana market and a growing recreational market, many investors are looking for ways to benefit from this growing opportunity. But the reality is that marijuana use is still against Federal law. This creates a tremendous amount of risk for investors. Banks don't want to do business with marijuana-focused businesses because they don't want to have exposure to federal charges such as money laundering. Marijuana businesses that break federal laws also can't take advantage of federal tax advantages. Many of the issues were highlighted in the 60 Minutes segment video Medical Marijuana Millionaires: Investing in Marijuana's "Green Rush"- Cheryl Shuman. So if you want to invest in the marijuana market, staying on the right side of the law is smart risk management.
Understanding the above, I was intrigued to read in Medical Marijuana's recent press release, Medical Marijuana Inc. and Portfolio Company Red Dice Holdings Launches Re-Brand of Innovative Hemp Oil Wellness Product Line, the statement that "Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act." I wondered how this statement could be true when I knew that Medical Marijuana's portfolio company, Red Dice Holdings, LLC, product line Dixie Elixirs contains THC. The capture below was taken from the Dixie Elixirs & Edibles media kit, which can be found at the Dixie Elixirs - About page.
To resolve what seemed to be a conflict of information, I contacted the company's Investor Relations department requesting clarification. I noted that "I understand the THC infused products are sold in Colorado where they are legal on the state level, but these statements still seem contrary to U.S. Federal law." I received the following response: "Simply put, Red Dice and MJNA own a brand of products it licenses to state licensed manufactures of products. Those companies [corrected] create state legal products. We do not grow, sell or distribute any products not federally legal."
Licensing is one of the most powerful tools a company can use to generate revenue. In the typical arrangement, the licensor, or inventor, grants the licensee, or manufacturer, use of intellectual property in return for royalties. This can take many burdens off of the licensor, such as production, inventory and overhead costs, but more importantly in this case, the risk of federal government prosecution and the ever-present persecution by the politically motivated.
Other companies such as Cannabis Science (CBIS.OB), which focuses more on pharmaceutical products to treat illnesses, benefit from licensing arrangements, but the licensing strategy is especially beneficial for companies like Medical Marijuana, which can and will focus on both the medicinal and recreational sides of the business. I think both companies are good investments.
Medical Marijuana has recently retained an accounting firm to audit its financials with the goal of up-listing to become a fully reporting company, as it stated in its recent press release, Medical Marijuana Inc. Retains Accounting Firm Anthony W. Imbimbo & Associates to Perform Financial Audit. The company then pre-announced its Q4 revenues numbers prior to its first audit, boasting an 1100% increase over the prior year. This is a good indicator of management confidence. So what kind of future revenue should we expect from Medical Marijuana?
If Medbox is any indication, the recent run-up could continue into the future for some very nice gains. Medical Marijuana has a rather large share count of about 736.45M, as reported by Yahoo Finance. The company reported a profitable fourth quarter Net Income of 3.39M on gross revenues of 5.10M. That would put the stock at about 14 cents, with a P/E of about 30 as shown in the chart below:
(click to enlarge)
The chart also illustrates what the price would be with 1000% growth in 2013 and 2014 with the same margins as 2012 and a PE of 30. Years 2015 and beyond start to trail off the growth and PE to account for the business becoming more mature. Growth would mostly be realized by expanding operations in states that currently have some form of legalized access, and then accessing new markets as other states legalize some form of marijuana use. Some suggest that the marijuana market is between $35 and 45 billion, and could reach as high as $100 billion.
Keep in mind that Medical Marijuana is a portfolio company, and revenue streams can come from multiple sources. It currently has the following companies in its portfolio:
PhytoSPHERE Systems, LLC - Developer and Builder of Cannabinoid Based Biotechnology
Red Dice Holdings, LLC - Taken from MJNA's website "Established as a holding company, Red Dice Holdings LLC owns the formulas, equipment, and extraction processes for Hemp oil based products. The company's [corrected] revenue model is to continue to develop these products and license them to distributors throughout the world."
HempMeds RX - Develops specialty health and wellness products derived from Hemp extracts and compounds
Wellness Managed Services - Taken from MJNA's website, "Wellness Managed Services engages in the management, capitalization and development of Health and Wellness facilities, Medical Clinics and Cooperatives throughout North America."
CanChew Biotechnologies - A new breakout product line that provides a Cannabidiol [CBD] based chewing gum. This product is designed to provide some of the benefits associated with marijuana without the psychotropic effects of THC. More information can be found at CanChew's website.
Medical Marijuana seems to have the cannabis-based business surrounded, but it will face lots of competition as the market expands. It definitely will have a significant first-mover advantage that could prove to be very lucrative for early investors that have a little pioneer spirit. I say pioneer spirit because navigating the regulatory environment that is hampered by political interests will be very difficult, and not every company vying in this market will survive the journey.
Additionally, micro-cap stocks like Medical Marijuana and Cannabis Science are inherently more risky. Most mutual funds have charters that prevent them from investing in these types of companies. They are also more volatile simply because of their size and cost per share. Also, as with any business, management must perform well. So make sure you follow the financial reporting closely.
In its 3rd Qtr results posted in November, Medical Marijuana showed in its press release, Medical Marijuana Inc. Reports Third Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1500 Percent From Same Period Last Year, significant entry level achievements to becoming a respected and bedrock company. As mentioned above, the company wants to have the numbers for the pre-released Q4 certified by its new accounting firm, Anthony W. Imbimbo & Associates. This willingness and confidence to subject the company to financial audits is certainly a positive sign that things are going well. And the Q4 results did show where the rubber met the road. Medical Marijuana's plan is to initially audit the Q4 results and then audit the full year's financials, ultimately examining 24 months of financial reports to support the requirements for up-listing the stock.
The marijuana business is rapidly gaining legitimacy across the United States as having medical benefits. The road is a little slower for the acceptance of recreational use, but new laws in the states of Colorado and Washington have raised the issue to a level that cannot be ignored in perpetuity. In our nation's capital, Washington, DC, the progression of medical marijuana laws will firmly put the issues on the front steps of U.S. legislators, almost literally. The first cultivation center is slated for the NW section of the city in the Ivy City neighborhood, and the first dispensary will be located about 13 blocks from the U.S. Capital Building. The map above shows the dispensary location in the upper right area marked with the purple tack pointer, and the U.S. Capital only a few blocks below.
Normally, these types of growth investments focus on disruptive technologies. This investment is very different in that it is an investment in a product that has a national market that is largely illegal, but is migrating to a legitimate market. Whether for medicinal or recreation purposes, the use of marijuana will continue to become more widely accepted.
Furthermore, with the U.S. debt problem, one would think that tapping into a federal tax base that is "low hanging fruit" by implementing taxes on the sale of marijuana would be a no-brainer for U.S. government leaders. That would be a win-win for the companies in this growing industry, consumers, the government, and potentially, investors.
Disclosure: I am long MJNA.PK, CBIS.OB. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
//-//////The acceptance of marijuana as a medicine is slowly gaining popularity. This market alone has a tremendous potential to change the landscape of the pharmaceutical product lines as more and more states allow their citizens access to marijuana. But medicinal marijuana is only half of the market. The other half of the market is selling marijuana for recreational use. Let's face it: some people just want to get high. Until now, most thought that Medbox, Inc. (MDBX.PK) was the only legitimate route to investing in the marijuana industry that included THC, which is the component in marijuana that provides the psychotropic effects (the buzz) that recreational users desire. But Medical Marijuana, Inc. (MJNA.PK) also has a method for legal entry into the market for the effects of THC that is not widely understood. I'm talking about licensing.
Medbox's primary value is derived from its subsidiary Prescription Vending Machines, Inc. Medbox provides a way for entrepreneurs in the medical marijuana industry to sell their products without a sales force. Transactions are completed using vending machines that read biometric input from users to verify identity for authorization to receive the dispensed products.
(click to enlarge)
This ability to legally reach the market and show actual results has proven to be extremely rewarding for some shareholders of Medbox. The six month chart above from Yahoo Finance shows a whopping increase of 2,595%.
Initially trading around $2.90, the stock briefly soared as high as $205 in mid-November before steadying to trade around its January 18th closing price of $78.15. Medbox recently announced a 1000% increase in cash reserves in its January 2, 2013 Q4 revenue figures from the prior quarter. Some believe that Medbox could decline as much as 50%. There is no doubt that Medbox seems to be extremely overpriced. Luckily, there are other alternatives to investing in the marijuana industry's THC-focused market that are more reasonably priced.
The portion of the market mentioned above that looks to use marijuana for recreational use is not completely untapped. Obviously, some who claim to need medicinal benefits do so just to gain access for leisure. But even if you exclude those who have found loopholes to gaining access, there is still a large population that will use marijuana as more and more states legalize recreational use. With Colorado and Washington leading the U.S. with their legalization of recreational use, you can be sure that other states will follow. Hawaii state House Speaker Joe Souki introduced House Bill 150, the Personal Use of Marijuana Act, which would allow adults that are 21 years or older to have a limited amount of marijuana for personal use.
With an established medical marijuana market and a growing recreational market, many investors are looking for ways to benefit from this growing opportunity. But the reality is that marijuana use is still against Federal law. This creates a tremendous amount of risk for investors. Banks don't want to do business with marijuana-focused businesses because they don't want to have exposure to federal charges such as money laundering. Marijuana businesses that break federal laws also can't take advantage of federal tax advantages. Many of the issues were highlighted in the 60 Minutes segment video Medical Marijuana Millionaires: Investing in Marijuana's "Green Rush"- Cheryl Shuman. So if you want to invest in the marijuana market, staying on the right side of the law is smart risk management.
Understanding the above, I was intrigued to read in Medical Marijuana's recent press release, Medical Marijuana Inc. and Portfolio Company Red Dice Holdings Launches Re-Brand of Innovative Hemp Oil Wellness Product Line, the statement that "Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act." I wondered how this statement could be true when I knew that Medical Marijuana's portfolio company, Red Dice Holdings, LLC, product line Dixie Elixirs contains THC. The capture below was taken from the Dixie Elixirs & Edibles media kit, which can be found at the Dixie Elixirs - About page.
To resolve what seemed to be a conflict of information, I contacted the company's Investor Relations department requesting clarification. I noted that "I understand the THC infused products are sold in Colorado where they are legal on the state level, but these statements still seem contrary to U.S. Federal law." I received the following response: "Simply put, Red Dice and MJNA own a brand of products it licenses to state licensed manufactures of products. Those companies [corrected] create state legal products. We do not grow, sell or distribute any products not federally legal."
Licensing is one of the most powerful tools a company can use to generate revenue. In the typical arrangement, the licensor, or inventor, grants the licensee, or manufacturer, use of intellectual property in return for royalties. This can take many burdens off of the licensor, such as production, inventory and overhead costs, but more importantly in this case, the risk of federal government prosecution and the ever-present persecution by the politically motivated.
Other companies such as Cannabis Science (CBIS.OB), which focuses more on pharmaceutical products to treat illnesses, benefit from licensing arrangements, but the licensing strategy is especially beneficial for companies like Medical Marijuana, which can and will focus on both the medicinal and recreational sides of the business. I think both companies are good investments.
Medical Marijuana has recently retained an accounting firm to audit its financials with the goal of up-listing to become a fully reporting company, as it stated in its recent press release, Medical Marijuana Inc. Retains Accounting Firm Anthony W. Imbimbo & Associates to Perform Financial Audit. The company then pre-announced its Q4 revenues numbers prior to its first audit, boasting an 1100% increase over the prior year. This is a good indicator of management confidence. So what kind of future revenue should we expect from Medical Marijuana?
If Medbox is any indication, the recent run-up could continue into the future for some very nice gains. Medical Marijuana has a rather large share count of about 736.45M, as reported by Yahoo Finance. The company reported a profitable fourth quarter Net Income of 3.39M on gross revenues of 5.10M. That would put the stock at about 14 cents, with a P/E of about 30 as shown in the chart below:
(click to enlarge)
The chart also illustrates what the price would be with 1000% growth in 2013 and 2014 with the same margins as 2012 and a PE of 30. Years 2015 and beyond start to trail off the growth and PE to account for the business becoming more mature. Growth would mostly be realized by expanding operations in states that currently have some form of legalized access, and then accessing new markets as other states legalize some form of marijuana use. Some suggest that the marijuana market is between $35 and 45 billion, and could reach as high as $100 billion.
Keep in mind that Medical Marijuana is a portfolio company, and revenue streams can come from multiple sources. It currently has the following companies in its portfolio:
PhytoSPHERE Systems, LLC - Developer and Builder of Cannabinoid Based Biotechnology
Red Dice Holdings, LLC - Taken from MJNA's website "Established as a holding company, Red Dice Holdings LLC owns the formulas, equipment, and extraction processes for Hemp oil based products. The company's [corrected] revenue model is to continue to develop these products and license them to distributors throughout the world."
HempMeds RX - Develops specialty health and wellness products derived from Hemp extracts and compounds
Wellness Managed Services - Taken from MJNA's website, "Wellness Managed Services engages in the management, capitalization and development of Health and Wellness facilities, Medical Clinics and Cooperatives throughout North America."
CanChew Biotechnologies - A new breakout product line that provides a Cannabidiol [CBD] based chewing gum. This product is designed to provide some of the benefits associated with marijuana without the psychotropic effects of THC. More information can be found at CanChew's website.
Medical Marijuana seems to have the cannabis-based business surrounded, but it will face lots of competition as the market expands. It definitely will have a significant first-mover advantage that could prove to be very lucrative for early investors that have a little pioneer spirit. I say pioneer spirit because navigating the regulatory environment that is hampered by political interests will be very difficult, and not every company vying in this market will survive the journey.
Additionally, micro-cap stocks like Medical Marijuana and Cannabis Science are inherently more risky. Most mutual funds have charters that prevent them from investing in these types of companies. They are also more volatile simply because of their size and cost per share. Also, as with any business, management must perform well. So make sure you follow the financial reporting closely.
In its 3rd Qtr results posted in November, Medical Marijuana showed in its press release, Medical Marijuana Inc. Reports Third Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1500 Percent From Same Period Last Year, significant entry level achievements to becoming a respected and bedrock company. As mentioned above, the company wants to have the numbers for the pre-released Q4 certified by its new accounting firm, Anthony W. Imbimbo & Associates. This willingness and confidence to subject the company to financial audits is certainly a positive sign that things are going well. And the Q4 results did show where the rubber met the road. Medical Marijuana's plan is to initially audit the Q4 results and then audit the full year's financials, ultimately examining 24 months of financial reports to support the requirements for up-listing the stock.
The marijuana business is rapidly gaining legitimacy across the United States as having medical benefits. The road is a little slower for the acceptance of recreational use, but new laws in the states of Colorado and Washington have raised the issue to a level that cannot be ignored in perpetuity. In our nation's capital, Washington, DC, the progression of medical marijuana laws will firmly put the issues on the front steps of U.S. legislators, almost literally. The first cultivation center is slated for the NW section of the city in the Ivy City neighborhood, and the first dispensary will be located about 13 blocks from the U.S. Capital Building. The map above shows the dispensary location in the upper right area marked with the purple tack pointer, and the U.S. Capital only a few blocks below.
Normally, these types of growth investments focus on disruptive technologies. This investment is very different in that it is an investment in a product that has a national market that is largely illegal, but is migrating to a legitimate market. Whether for medicinal or recreation purposes, the use of marijuana will continue to become more widely accepted.
Furthermore, with the U.S. debt problem, one would think that tapping into a federal tax base that is "low hanging fruit" by implementing taxes on the sale of marijuana would be a no-brainer for U.S. government leaders. That would be a win-win for the companies in this growing industry, consumers, the government, and potentially, investors.
Disclosure: I am long MJNA.PK, CBIS.OB. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
props to igor for posting this months ago..
http://www.bgol.us/board/showthread.php?p=12097185&highlight=mjna#post12097185
bought high..sold even higher, though I am banking on HEMP reaching and maybe surpassing MJNA
Anymore stock picks igor????
http://www.bgol.us/board/showthread.php?p=12097185&highlight=mjna#post12097185
bought high..sold even higher, though I am banking on HEMP reaching and maybe surpassing MJNA
Anymore stock picks igor????
NTAP - NetApp
NetApp, Inc. engages in design, manufacture, marketing, and technical support of networked storage solutions. The company supply enterprise storage and data management software, and hardware products and services.
NetApp, Inc. engages in design, manufacture, marketing, and technical support of networked storage solutions. The company supply enterprise storage and data management software, and hardware products and services.
VMW - VMware
VMware, Inc. provides virtualization and virtualization-based cloud infrastructure solutions in the United States and internationally.
VMware, Inc. provides virtualization and virtualization-based cloud infrastructure solutions in the United States and internationally.
If you get your investment advice from a porn board you deserve whatever happens to your dumb ass.
I was hoping they brought this thread back. Props Kaya you got some legit tips. Still kicking myself on that Sirius I had it at .50 and got out
I been doing decent with a half assed approach. im ready to put some full time effort in and see what happens
You sir are correct. I got 2 nice returns thus far.. Real nice.
What people are doing here are giving u their pics. From there, do your homework and then make a dsecision.
Been working A-OK for me
U sold me on the Hemp/MJNA. Yea im a stoner, but it looks good to me
Respect for acknowledging i alerted MJNA months ago and cats were clowning. I like MJNA better than HEMP but both should be good plays depending on entry points. All medical marijuana stocks exploded last week so they will probably cool off in the coming weeks. I like to mix it up with common big board stocks, options, and penny plays. I turned 90$ into 2000$ overnight with BIDU call options last year. I like ARNA right now, a pharmaceutical company with an FDA approved fat loss pill that has yet to be sold on the market. Its trading at 8.60 a share now, if sales of the pill are good its an easy 15$ a share stock by years end, if the sales are bad it heads down to 6$ or so. I also like BBRY (formally RIMM)as a comeback story. Company is too big to fail for Canada so it wont sink until it really has to. Also may want to check out JOEZ a designer jeans co which can potentially double by end of year. Good luck and as always never blindly follow anyones trades and KNOW what you own. Hope MJNA had you
like me
Respect for acknowledging i alerted MJNA months ago and cats were clowning. I like MJNA better than HEMP but both should be good plays depending on entry points. All medical marijuana stocks exploded last week so they will probably cool off in the coming weeks. I like to mix it up with common big board stocks, options, and penny plays. I turned 90$ into 2000$ overnight with BIDU call options last year. I like ARNA right now, a pharmaceutical company with an FDA approved fat loss pill that has yet to be sold on the market. Its trading at 8.60 a share now, if sales of the pill are good its an easy 15$ a share stock by years end, if the sales are bad it heads down to 6$ or so. I also like BBRY (formally RIMM)as a comeback story. Company is too big to fail for Canada so it wont sink until it really has to. Also may want to check out JOEZ a designer jeans co which can potentially double by end of year. Good luck and as always never blindly follow anyones trades and KNOW what you own. Hope MJNA had you
Im a rookie at stocks, can you(or anyone) elaborate on call options and how they work?
Props for this thread. I plan on opening up either an Ameritrade or Scottrade account as soon as I receive back my tax refund
How to start trading
1. Figure out how much you want to trade with e.g. $500 or $1000
Make sure that is money that you can stand to lose up half of it as a worse case scenario.
Once you are at that comfort level then you will have already prepared for the worst and it is only up from here!
2. Choose a brokerage
I use tdameritrade.
Others use scottrade.
I have had my account for a number of years so you may want to check the offers they currently have.
The trading platform is not so important as the actual trades themselves at this stage.
I also set up an electronic transfer connecting it to my checking account so that i could transfer money into the trading account and back to the checking account.
TDameritrade allows you to also use fake money to learn to use the platform.
That is an advantage for those now starting out.
3. Set up watch list of stocks you may be interested in.
4. Talk to other people who trade to learn what they think about other companies, trading strategies, stock leads etc.
This weekend i am also setting up the bgol stock market game so come monday we can all jump in with$1 million and learn to make trades, learn to read financial statements, interpret filings and have a good read on the economy as a whole.
All positive things so don't feel intimidated cause we all learn.
Kayan You started the virtual thread
booked
Similar threads
